Important points
- On November 20, 2025, stock prices of chip manufacturers central to the AI boom saw a decline after a brief increase. Conversely, strong earnings reports led to a rise in the prices of major retailers.
- Nvidia’s stock ended lower despite reporting higher-than-expected profits the previous day.
- Walmart exceeded analysts’ expectations with its quarterly results, resulting in a hike in its stock price.
Shares of some of the world’s largest companies lost steam after promising earnings announcements, while major retailers experienced gains following their quarterly results that surpassed predictions.
U.S. stock indexes closed in the red on Thursday as the postponed September jobs report presented mixed signals. Nvidia’s shares fell 3.2% after initial gains, despite better-than-expected quarterly results, leading the tech sector’s decline.
Nvidia was among the worst performers on the Dow Jones Industrial Average that day, dropping 0.8%. The S&P 500 decreased by 1.6%, and the tech-focused Nasdaq saw a drop of 2.2%. For further details about Thursday’s market trends, see here.
Together with Nvidia, shares of other AI chip manufacturers declined. Advanced Micro Devices (AMD) saw a nearly 8% drop, Broadcom (AVGO) fell by 2%, and the PHLX Semiconductor Index was down almost 5%. Micron Technology (MU), Nvidia’s memory chip partner, experienced a significant decline of 10.9%.
Among S&P 500 stocks, Jacobs Solutions (J) stood out as the biggest loser, plummeting nearly 11% after reporting a drop in quarterly profits compared to the previous year. The company attributed this to a change in the value of its investment in Amentum (AMTM), which it separated from last year, merging its prior intelligence and cyber divisions.
Bitcoin’s price continued its downward trend, stabilizing around $87,000. Shares of Robinhood Markets (HOOD), which facilitates cryptocurrency trading, fell about 10%, while Coinbase Global (COIN), a cryptocurrency exchange operator, saw a 7.4% decline.
Walmart (WMT) stock surged nearly 7% on Thursday, marking the best performance on the S&P 500 index after the retail giant’s profits exceeded analyst expectations. The year-over-year growth in e-commerce sales and advertising revenue bolstered this strong performance, hinting at potentially positive trends for U.S. consumer spending as the holiday season approaches.
Regeneron Pharmaceuticals (REGN) received FDA approval for the use of its Eylea HD eye treatment in patients with macular edema following retinal vein occlusion. Regulators also authorized a monthly dosing option for Eylea HD for various eye conditions. Following this news, Regeneron’s stock climbed 5%.
Shares of Solventum (SOLV), a healthcare firm that was spun off from 3M (MMM) last year, rose nearly 3% after announcing it would acquire Acela Surgical, a bioscience company specializing in wound regeneration. Solventum plans to pay Acela $725 million upfront, with additional payments of up to $125 million possible based on certain achievements.
